home / stock / cocp / cocp short
Short Information | Cocrystal Pharma Inc. (NASDAQ:COCP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 68,994 |
Total Actual Volume | 349,543 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 1 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 3,450 |
Average Short Percentage | 18.09% |
Is there a COCP Short Squeeze or Breakout about to happen?
See the COCP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-25-2024 | $1.56 | $1.51 | $1.57 | $1.51 | 1,699 | 556 | 32.73% |
04-24-2024 | $1.59 | $1.5559 | $1.59 | $1.5 | 3,850 | 1,231 | 31.97% |
04-23-2024 | $1.59 | $1.562 | $1.59 | $1.562 | 741 | 93 | 12.55% |
04-22-2024 | $1.53 | $1.52 | $1.57 | $1.51 | 9,707 | 333 | 3.43% |
04-19-2024 | $1.545 | $1.5299 | $1.5999 | $1.48 | 7,631 | 1,062 | 13.92% |
04-18-2024 | $1.47 | $1.495 | $1.495 | $1.4601 | 5,074 | 256 | 5.05% |
04-17-2024 | $1.4726 | $1.43 | $1.5304 | $1.4196 | 8,388 | 3,129 | 37.3% |
04-16-2024 | $1.4 | $1.46 | $1.5211 | $1.35 | 19,168 | 9,649 | 50.34% |
04-15-2024 | $1.45 | $1.4079 | $1.49 | $1.39 | 22,345 | 1,975 | 8.84% |
04-12-2024 | $1.5568 | $1.45 | $1.5568 | $1.44 | 13,359 | 513 | 3.84% |
04-11-2024 | $1.58 | $1.55 | $1.58 | $1.51 | 7,596 | 1,160 | 15.27% |
04-10-2024 | $1.57 | $1.5799 | $1.5996 | $1.5019 | 9,971 | 1,411 | 14.15% |
04-09-2024 | $1.54 | $1.55 | $1.601 | $1.5184 | 9,641 | 700 | 7.26% |
04-08-2024 | $1.65 | $1.56 | $1.67 | $1.521 | 9,127 | 1,727 | 18.92% |
04-05-2024 | $1.42 | $1.595 | $1.63 | $1.42 | 60,255 | 21,070 | 34.97% |
04-04-2024 | $1.43 | $1.47 | $1.5371 | $1.42 | 21,774 | 4,000 | 18.37% |
04-03-2024 | $1.48 | $1.4338 | $1.55 | $1.4244 | 8,258 | 1,203 | 14.57% |
04-02-2024 | $1.51 | $1.48 | $1.5482 | $1.46 | 10,128 | 780 | 7.7% |
04-01-2024 | $1.5 | $1.5 | $1.5516 | $1.4 | 37,784 | 6,143 | 16.26% |
03-28-2024 | $1.53 | $1.4 | $1.74 | $1.4 | 83,047 | 12,003 | 14.45% |
News, Short Squeeze, Breakout and More Instantly...
Cocrystal Pharma Inc. Company Name:
COCP Stock Symbol:
NASDAQ Market:
Cocrystal Pharma Inc. Website:
FDA feedback following the Company’s submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a broad-spectrum PB2 inhibitor Topline data expected in 2024 from Phase 2a influenza A human challen...
Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash., March 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received Pre-Investigational New D...
LOS ANGELES, CA / ACCESSWIRE / March 5, 2024 / Planet MicroCap today published a new Video Interview with Jim Martin, Co-CEO and CFO, from Cocrystal Pharma, Inc. (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replicat...